Both Darzalex and Elotuzamab were FDA approved about 2015. Darzalex targets CD38 and Elotuzamab targets SLAM7. Pomalyst is a newer IMID. It is more potent than Revlimid. I actually tolerate it better than I did Revlimid. I hope you do well on this new protocol. šššš
I made a mistake. Iām on pomalyst and darzelex. Not dexamethasone.
For now they are going good for me
Iām on pomalyst and dexamethasone. I have never heard of elotuzumab or daratumamab. ? Are they new??